Are two month prescriptions back on the government's agenda? Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) that prescription lengths be doubled to two months for a range of medicines may be back on the government agenda, new documents reveal. The proposals appeared to have been scrapped before the 2019 Federal Budget was delivered, following
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.